Navigating Employee Background Screening & Drug Testing During COVID-19
Navigating Employee Background Screening & Drug Testing During COVID-19

On Demand Webinar

The Details

Duration: 50 minutes

Presented By: EBI & Rhodes Hieronymus

Recorded from the live presentation on 4/9/2020.

What You’ll Learn:

  • Why it is essential that you continue your background and drug testing programs
  • COVID-19’s effect on information retrieval
  • Avoiding hiring delays while staying compliant
  • Changes regarding onboarding for remote workers
  • Managing a screening crunch once the crisis has passed


More Information


As businesses struggle with these extraordinary and unprecedented times, there are many changes to be considered in regards to obtaining and using the information on background and drug testing reports.

Curt Schwall, EBI’s VP of Compliance & Regulatory Affairs, and attorney Larry Henry of Rhodes Hieronymus, help guide you through this new landscape.

Access the Recording & Slide Deck:

About the Presenters:

Larry D. Henry

Larry D. Henry is of counsel at Rhodes Hieronymus. His areas of specialization include Fair Credit Reporting Act and Driver Privacy Protection Act.

Denelda L. Richardson

Denelda L. Richardson is a partner in Rhodes Hieronymus whose practice focuses on litigation and appellate practice, with an emphasis on claims of employment discrimination under both federal and state law.

Curt Schwall

Curt is Vice President of Compliance and Regulatory Affairs at EBI. His experience in the screening industry spans more than 20 years, and includes three terms on the Board of Directors for the Professional Background Screening Association (PBSA).

Jennifer Gladstone

As Editor-in-Chief of the Screening News Network, Jennifer keeps EBI’s customers and blog subscribers up-to-date on the latest screening news and legislative alerts affecting companies of all sizes.